Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Langere overleving bij toevoeging van abirateron
aug 2017 | Uro-oncologie